V8 Peptides — Engineered Performance
Research Library
NAD+ and Mitochondria: Respirometry and Mitonuclear Readouts
NAD+Guide

NAD+ and Mitochondria: Respirometry and Mitonuclear Readouts

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

What does preclinical research say about NAD+ and mitochondrial function? Published mouse and cell studies connect NAD+ supply to mitochondrial readouts through sirtuins. A 2013 study reported that aging mice lose mitochondrial-encoded OXPHOS subunits through a pathway driven by declining nuclear NAD+, and that raising NAD+ in old mice restored mitochondrial function in a SIRT1-dependent manner (Gomes et al., 2013). Nicotinamide riboside raised NAD+ and activated SIRT1 and SIRT3 in cells and mouse tissues (Cantó et al., 2012), and a 12-month nicotinamide mononucleotide study in mice reported enhanced mitochondrial oxidative metabolism in skeletal muscle (Mills et al., 2016). This page is about the measurements: respirometry, mitonuclear protein balance, compartment-specific NAD+ and the controls each needs. For laboratory research use only; see the NAD+ 1000 mg product page and NAD+ research overview.

Statements that NAD+ supports mitochondrial function are common; the underlying experiments are more specific and more constrained. This article reads the primary studies for what was actually measured, then turns them into a measurement plan a laboratory could use to ask the question in its own cells or animals. It is about assay choice, not outcomes, and it does not recommend any use of the compound outside a research setting. The product is supplied for laboratory research use only; not for human consumption.

Why NAD+ and mitochondria are linked

NAD+ is a coenzyme for redox reactions and a cosubstrate for sirtuins and PARPs (Verdin, 2015); in mitochondria it carries electrons between dehydrogenases and the respiratory chain, and it is consumed by mitochondrial sirtuins. The link is therefore both metabolic (redox carrier) and regulatory (sirtuin substrate). Houtkooper and colleagues' review frames NAD+ as an old metabolite controlling new metabolic signaling pathways, spanning the pathways that control NAD+ production and cycling, its compartmentalization, the signaling and transcriptional pathways it controls, and the physiological impact of modulating NAD+-producing and -consuming pathways (Houtkooper et al., 2010).

The mitochondrial pool is the largest subcellular pool and is maintained by dedicated routes. Nikiforov and colleagues showed that mitochondrial NAD synthesis proceeds from NMN, taken into the matrix, by NMNAT3 (Nikiforov et al., 2011), and Cambronne and colleagues showed with a biosensor that free NAD+ in mitochondria approximates the Michaelis constants of the local NAD+-consuming enzymes, with cell-specific mechanisms maintaining the mitochondrial concentration (Cambronne et al., 2016). Those facts set the problem: a measurement of whole-cell NAD+ may say little about the mitochondrial pool.

What the key studies measured

Aging and mitonuclear communication. Gomes and colleagues showed that during aging there is a specific loss of mitochondrial-encoded, but not nuclear-encoded, OXPHOS subunits. They traced the cause to a PGC-1alpha/beta-independent pathway of nuclear-mitochondrial communication induced by a decline in nuclear NAD+ and accumulation of HIF-1alpha under normoxic conditions, described as a pseudohypoxic state. Deleting SIRT1 accelerated the process, while raising NAD+ levels in old mice restored mitochondrial function to that of a young mouse in a SIRT1-dependent manner (Gomes et al., 2013).

Precursor supplementation. Cantó and colleagues reported that NR supplementation in mammalian cells and mouse tissues increased NAD+ levels and activated SIRT1 and SIRT3, with enhanced oxidative metabolism and protection against high-fat diet-induced metabolic abnormalities in mice (Cantó et al., 2012).

Long-term NMN in mice. Mills and colleagues administered NMN for 12 months to wild-type mice during normal aging and reported that it was quickly used to synthesize NAD+ in tissues, suppressed age-associated body-weight gain, enhanced energy metabolism and physical activity, and in skeletal muscle enhanced mitochondrial oxidative metabolism and mitonuclear protein imbalance, along with effects on gene expression in key metabolic organs (Mills et al., 2016).

Reviews. Covarrubias and colleagues reviewed NAD+ metabolism and its roles in processes including DNA repair, chromatin remodeling, senescence and immune function, and note that much remains to be learned about how NAD+ influences biology and ageing (Covarrubias et al., 2021).

StudyModelMitochondria-relevant finding in the abstractWhat it does not establish
Gomes et al., 2013Aging mice; cellsLoss of mitochondrial-encoded OXPHOS subunits tied to nuclear NAD+ decline; SIRT1-dependent restoration in old miceApplicability beyond the models used
Cantó et al., 2012Mammalian cells; mice on high-fat dietNR raised NAD+, activated SIRT1 and SIRT3, enhanced oxidative metabolismWhich compartment's NAD+ rose
Mills et al., 2016Wild-type mice, 12 monthsEnhanced mitochondrial oxidative metabolism in skeletal muscle; mitonuclear protein imbalance affectedMechanism in each tissue
Cambronne et al., 2016Cells with biosensorFree NAD+ in mitochondria approximates Km of local enzymesDynamics under every perturbation

A measurement plan

A study asking whether a change in NAD+ supply alters mitochondrial function needs readouts at four levels, listed from the metabolite to the phenotype.

  1. NAD+ itself, by compartment. Total NAD+ and NADH from carefully extracted lysates, plus a compartment-targeted measurement if the question is mitochondrial (Cambronne et al., 2016; Nikiforov et al., 2011).
  2. Sirtuin engagement. Deacetylation of known substrates and, where possible, SIRT1 or SIRT3 depletion to test dependence, as in the SIRT1 dependence experiments of Gomes et al.
  3. Mitonuclear protein balance. Protein or transcript levels of mitochondrial-encoded OXPHOS subunits relative to nuclear-encoded ones; this is the readout used in the aging work (Gomes et al., 2013) and referred to in the NMN study (Mills et al., 2016).
  4. Function. Oxygen consumption by respirometry in intact or permeabilized cells with substrate and inhibitor sequences, membrane potential, and ATP content.

The pairing of level 3 with level 4 is what lets a study separate a change in mitochondrial content from a change in mitochondrial function. Normalizing respiration to mitochondrial mass (for example a mitochondrial DNA copy number or citrate synthase activity) is a standard guard against confusing the two.

LevelMethodControlCommon confound
MetaboliteLC-MS or enzymatic cycling for NAD+/NADH; targeted sensorSpiked recovery; vehicleNADH oxidation during extraction
Sirtuin activitySubstrate acetylation; sirtuin knockdownCatalytically dead or knockdown cellsOff-target effects of inhibitors
Mitonuclear balanceMitochondrial-encoded vs nuclear-encoded OXPHOS subunitsYoung vs aged or untreated cellsAntibody cross-reactivity
RespirationOxygen consumption with substrate and inhibitorsNormalization to mitochondrial massChanges in cell number or substrate supply
PhenotypeMembrane potential, ATP, ROSUncoupler and inhibitor controlsDye loading artifacts

Controls and caveats specific to NAD+ work

  • Delivery. Extracellular NAD+ is degraded to permeable precursors before entering cells (Nikiforov et al., 2011), so an effect of adding NAD+ may reflect its breakdown products; include a precursor comparison and measure intracellular levels.
  • Dependence. Demonstrate that an effect requires the proposed mediator, for example SIRT1 in the aging study, rather than inferring it from the pathway diagram.
  • Dose logic. Because supplementation studies differ by precursor, species and duration, results should not be compared across studies as if the exposures were equal. Tissue differences in biosynthetic enzymes also mean that a precursor that raises NAD+ in one tissue may not do so in another, so each tissue of interest should be measured directly.
  • Species and age. Findings in aged mice may not match young animals or cultured cells; state age, sex and strain.
  • Reporting of null results. A raised NAD+ level without a mitochondrial change is informative about the model and should be reported.

Time matters as well. Sirtuin-dependent changes in mitochondrial protein composition develop over days, not minutes, whereas respirometry can change within hours, so the sampling schedule should match the readout: early points for metabolite and acetylation changes, later points for protein-balance changes. Include a time-matched vehicle at every point, because cells in culture drift as nutrients are consumed and passage number rises. When animals are used, record age, sex, strain, diet and housing, since the aging study's central claim depends on age and the high-fat diet study's on diet.

Mitochondrial readouts are also sensitive to culture conditions: glucose or galactose medium, oxygen tension and passage number change respiration, so fix and record them.

Handling the research material

The NAD+ 1000 mg product page lists NAD+ as a 1000 mg lyophilized powder with formula C21H27N7O14P2, purity stated as at least 98%, stored at 2–8 °C or at −20 °C long term and protected from heat, moisture and light. A COA is marked as coming soon on the page; check it before relying on lot documentation and see NAD+ purity testing and the COA page. Prepare stock concentrations with the molar mass and the calculator, record the time between preparation and use because NAD+ in solution is chemically labile, and keep a handling log. Related reading: NAD+ research applications, the NAD+ and MOTS-c blend explainer and the shop.

Frequently asked questions

Does the literature link NAD+ to mitochondrial function?

Yes, in cell and mouse studies, mainly through sirtuins; for example Gomes et al. tied declining nuclear NAD+ to loss of mitochondrial-encoded OXPHOS subunits in aging mice.

What is the pseudohypoxic state?

A condition described in the 2013 study in which declining nuclear NAD+ and HIF-1alpha accumulation under normoxia disrupt nuclear-mitochondrial communication.

Which sirtuins did NR activate?

SIRT1 and SIRT3 in mammalian cells and mouse tissues (Cantó et al., 2012).

What did the 12-month NMN mouse study measure?

Body weight, energy metabolism, physical activity, insulin sensitivity and mitochondrial oxidative metabolism in skeletal muscle, among others (Mills et al., 2016).

Why measure compartment-specific NAD+?

Free NAD+ in the nucleus, cytoplasm and mitochondria differs and relates to local enzyme Km values (Cambronne et al., 2016).

How is mitochondrial NAD made?

From NMN by NMNAT3 in the matrix (Nikiforov et al., 2011).

What is mitonuclear protein imbalance?

A difference in levels of mitochondrial-encoded versus nuclear-encoded OXPHOS subunits, used as a readout in the aging and NMN studies.

How should respiration be normalized?

To mitochondrial mass, such as mtDNA copy number or citrate synthase activity, so content changes are not read as function changes.

Does adding NAD+ to medium raise mitochondrial NAD+ directly?

Not necessarily; extracellular NAD+ is degraded to precursors first, so include precursor comparisons.

What is the NAD+ product format?

A 1000 mg lyophilized powder, at least 98% purity, formula C21H27N7O14P2, stored at 2–8 °C or −20 °C long term.

Responsible research use

Everything on this page is offered for laboratory research use only; it is background reading for qualified researchers, not guidance for any use outside a research setting, and nothing here is a claim about benefit in people or animals. Products from V8 Peptides are sold strictly as research materials: not a drug, food or cosmetic, and not for human or animal consumption. Published studies described here were run by their authors under their own approvals and protocols, and this page does not recommend repeating them.

Related reading: NAD+ in Axon Degeneration and Neurodegeneration Models, NAD+ Structure and Function: A Molecular Research Guide, NAD+ Stability: Degradation Chemistry and QC Checks.

References

  1. Verdin E. NAD+ in aging, metabolism, and neurodegeneration. Science. 2015;350(6265):1208-1213. doi:10.1126/science.aac4854
  2. Houtkooper RH, Cantó C, Wanders RJ, Auwerx J. The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev. 2010;31(2):194-223. doi:10.1210/er.2009-0026
  3. Nikiforov A, Dölle C, Niere M, Ziegler M. Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. J Biol Chem. 2011;286(24):21767-21778. doi:10.1074/jbc.M110.213298
  4. Cambronne XA, Stewart ML, Kim D, Jones-Brunette AM, Morgan RK, Farrens DL, et al. Biosensor reveals multiple sources for mitochondrial NAD+. Science. 2016;352(6292):1474-1477. doi:10.1126/science.aad5168
  5. Gomes AP, Price NL, Ling AJY, Moslehi JJ, Montgomery MK, Rajman L, et al. Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell. 2013;155(7):1624-1638. doi:10.1016/j.cell.2013.11.037
  6. Cantó C, Houtkooper RH, Pirinen E, Youn DY, Oosterveer MH, Cen Y, et al. The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 2012;15(6):838-847. doi:10.1016/j.cmet.2012.04.022
  7. Mills KF, Yoshida S, Stein LR, Grozio A, Kubota S, Sasaki Y, et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab. 2016;24(6):795-806. doi:10.1016/j.cmet.2016.09.013
  8. Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119-141. doi:10.1038/s41580-020-00313-x

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.